Expanding the reach of the p53 tumor suppressor network

Cell Death and Differentiation

Volumn 21, Issue 4, 2014, Pages 505-506

  Zambetti, G P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; PROTEIN P53;

ADRENAL CORTEX CARCINOMA; ALLELE; AMINO ACID SUBSTITUTION; ANGIOGENESIS; APOPTOSIS; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; COLON CARCINOMA; DNA BINDING; DNA DAMAGE; DNA REPAIR; EDITORIAL; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; INTRON; METASTASIS; MISSENSE MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896772419     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.13     Document Type: Editorial

References (13)

1. Vousden K, Prives C. Cell 2009; 137: 413-431.
2. Wang B et al. Cell Death Differ 2014; 21: 521-532.
3. El-Deiry WS et al. Nat Genet 1992; 1: 45-49.
4. El-Deiry WS et al. Cell 1993; 75: 817-825.
5. Chen X et al. Genes Dev 1996; 10: 2438-2451.
6. Petitjean A et al. Hum Mutat 2007; 28: 622-629.
7. Liu G et al. Nat Genet 2004; 36: 63-68.
8. Ribeiro RC et al. Proc Natl Acad Sci USA 2001; 98: 9330-9335.
9. Custó dio G et al. J Clin Oncol 2013; 31: 2619-2626.
10. Zambetti GP. J Cell Physiol 2007; 213: 370-373.
11. Kato S et al. Proc Natl Acad Sci USA 2003; 100: 8424-8429.
12. Hu W et al. Nature 2007; 450: 721-724.
13. Levine AJ, Hu W, Feng Z. Cell Death Differ 2006; 13: 1027-1036.